510(k) K905513
K905513 is an FDA 510(k) premarket notification submitted by Isolab, Inc. for the device "GLYC-AFFIN(TM)-GA". The FDA issued a decision of Substantially Equivalent on Jan 15, 1991. The device falls under product code LCP (Assay, Glycosylated Hemoglobin), a Class II device regulated under 21 CFR 864.7470. Isolab, Inc. has 43 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 15, 1991
- Date Received
- Dec 10, 1990
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Assay, Glycosylated Hemoglobin
- Device Class
- Class II
- Regulation Number
- 864.7470
- Review Panel
- HE
- Submission Type
- 510(k)
Need the full FDA record for Isolab, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.